Quantcast
Channel: BusinessWire India.com - Banking & Financial Services

MIRAI Capital Global Embarks on Strategic Expansion with Esteemed Industry Leaders Joining Its Investment Team and Advisory Board

$
0
0
Business Wire India
Building Bridges: Welcoming Esteemed Industry Leaders
Building Bridges: Welcoming Esteemed Industry Leaders

MIRAI Capital Global (MCG), a premier global investment fund, proudly announces a transformative expansion marked by the appointment of distinguished industry leaders to its Investment team and Advisory board. This strategic move reinforces MCG’s position, fortifying its capabilities with unmatched expertise across diverse sectors to propel the firm's global investment endeavours.
 
Under the visionary leadership of HH Sheikh Ahmed bin Faisal Al Qassimi, whose ethos centres on human capital as the true wealth, MCG is committed to attracting top-tier talent and nurturing business growth leveraging UAE for global markets. His Highness’ relentless belief in empowerment underscores MCG’s team expansion with the appointment of eminent leaders driving change and delivering significant value through their wealth of experience.
 
"We are thrilled to see the team expansion for MIRAI Capital Global with such remarkable global talent," said Dunston Pereira, Group CEO of the Royal Office of HH Sheikh Ahmed bin Faisal Al Qassimi for Strategic Alliances & Policies. "Their expertise will be instrumental in sourcing appropriate investment opportunities outside of UAE for business that is looking at expanding and leverage the policies and infrastructure in UAE and GCC markets, while also ensuring we meet all the strategic goals of this fund with the Royal Patronage. I am confident in this team and Chief Investment Officer and my esteemed colleagues' ability to forge synergistic ties across the US, GCC, and Asia. Together, we are not just bridging geographies; we are crafting a better world, grounded in mutual benefit and strategic achievement for long term."
 
"It is truly satisfying to witness the addition of global talent, united in the pursuit of our vision for MIRAI Capital," said Pranav Jyoti, the Co-founder and Managing Director of MCG. "With a targeted approach towards the rapidly expanding markets of the US, India, and UAE, this investment and advisory team holds the potential to unlock tremendous opportunities for growth and prosperity. Under the blessings of HH Sheikh Ahmed bin Faisal Al Qassimi, we have not only bought globally capital to UAE but also aim to bring the gems who will be the next googles of the world with a MENA and Asia consumption."
 
"As a team, we firmly believe in surrounding ourselves with people who are smarter than us," said Puneet Pandit, Co-founder and CEO of MCG. "Also, by bringing together individuals with diverse skill sets and perspectives, this team can now help us navigate the complexities of different cultures, regulations, and business practices as we grow MCG in the future."
 
Strategic Announcements:
 
Devang Mehta, the newly appointed Venture Partner focused on Secondaries market, brings a wealth of operational and investment experience to MCG. Formerly a General Partner at Anthill Ventures, Devang’s career spans across India and Silicon Valley, including notable roles at Morningstar (Nasdaq: MORN), eTouch (acquired by Virtusa), and Glassbeam (Series B funded Analytics firm). Holding degrees in Computer Science and Engineering, and an MBA from Carnegie Mellon University’s Tepper School of Business, Devang has invested in and incubated firms across various sectors, notably Gaia Smart Cities (IoT) and Erlysign (Early Cancer Detection using saliva).
 
"The move into the Secondaries market presents a compelling opportunity for MCG," commented Devang Mehta. "Our investments will aim to catalyse wealth creation across all stakeholders, offering attractive liquidity paths for investors."
 
Rakesh Vaidyanathan will assume the critical role of Venture Partner focused on US & Latin America sector helping raise new capital and bridging strategic discussions with funds and start-ups in that region. Rakesh has a BS in Electrical Engineering from Guindy Engineering School in Chennai along with MBA degrees from IIM Calcutta and Wharton School of Business. As the Founder Partner of The Jai Group, Rakesh has delivered tangible business growth through organic strategies and M&A engagements in diverse international markets for multiple businesses across several industry segments.
 
"Latin America, US and UAE regions form a very synergistic corridor to raise and deploy capital in Funds and Startups," said Rakesh Vaidyanathan. "With Jai Group’s deep expertise in these regions, I am looking forward to working with MCG team to contribute towards its future growth."
 
Advisory Positions Based in US/Silicon Valley:
 
Dr. Peter Fitzgerald is a medical doctor who specializes in interventional cardiology. He is also a co-founder of Triventures, a VC firm focused on the healthcare sector in Palo Alto and Tel Aviv. Additionally, he is a Professor Emeritus at Stanford Medical School and holds a PhD in Computer Science. Dr. Fitzgerald has been involved in more than 150 clinical trials, has published over 450 manuscripts and chapters, and has founded 24 healthcare companies in Silicon Valley. His significant contributions to the industry have helped 18 of these start-ups transition through M&A and IPO efforts. He continues to serve on the advisory boards of several medium and large-cap healthcare companies.
 
"Global healthcare communities are on the brink of significant advancements especially with AI," said Dr Peter Fitzgerald. "Leveraging MCG team’s vision & leadership will drive long-term value in the US, UAE, India, and beyond."
 
Ammar Hanafi is Co-Founder and General Partner of Moment Ventures specializing in early-stage tech startup investments targeting future of industry transformations. Ammar received a BS in Applied and Engineering Physics from Cornell University and an MBA from Stanford University. Prior to Moment, Ammar was at Alloy Ventures where he led investments in Mavenir Systems, Inc. (IPO in 2013 and acquired by Mitel in 2015) and Cortina Systems, Inc. (acquired by Inphi and Reltek in 2014) among others. Ammar previously served as VP of Corporate Development at Cisco Systems leading over 50 acquisitions and $750 million in venture capital investments.
 
"Talented entrepreneurs with deep domain experience are revolutionizing industries across the globe," said Ammar Hanafi. "As a founder of a Venture firm with deep experience in several B2B sectors, I am looking forward to advising the MCG team on its future growth."
 
Sri Peddu, is the General Partner and MD of Powerhouse Ventures focused on early-stage B2B tech ventures leveraging the US and India corridor. He leads his firm’s Investment Advisory Team tasked to source innovation while conducting deep market and company-specific due diligence and execute investments. His team has led investments into category-defining companies such as BigYellowFish, Hectar, Novatr, Quizizz, Slintel (6Sense), Sybill, and Whatfix. Upon graduating with a Master’s in International Affairs from The New School in New York City and a Bachelor’s from Loyola University, Chicago, Sri was formerly with the World Bank in Washington, DC.
 
"Our fund’s commitment to fostering innovation in the US-India market is truly at the right place and right time," said Sri Peddu. "Working as an Advisor to MCG team, I am eager to leverage my experience to contribute to its future success."
About MIRAI Capital Global

MIRAI Capital Global (MCG) stands at the forefront of global investment landscape committed to bridging the East with the West. Leveraging UAE as the fulcrum and using India and South-East Asia as high growth consumption markets, the primary Investment focus is to partner with VC firms as a “Fund-of-Funds” along with direct investments in start-ups as co-investment opportunities with specific industry focus on Healthcare, Education, Cleantech, Future of Industries, Technology and Growth Infrastructure, Fintech, Blockchain and AI.

LabVantage Celebrates Customer Success with Record Number of Software Deployments in FY 2024

$
0
0
Business Wire India

LabVantage Solutions, Inc., the leading provider of laboratory informatics solutions and services, including purpose-built LIMS solutions that allow labs to go live faster and at a lower total cost, today announced the global achievement of more than 100 software deployments or ‘Go-Lives’ by customers in fiscal year 2024 across all of the industries it supports, including pharmaceuticals, biotechnology, healthcare, oil and gas, and food and beverage.

 

The global life sciences LIMS market, currently valued at $1 billion, is expected to grow at an annual rate of 12-14% over the coming years, driven by a 10-12% yearly increase in user base.1 In this rapidly evolving sector, the demand for bespoke LIMS solutions that address the complexities of modern laboratory environments and deliver an integrated approach for scientific data management has become critical.

 

LabVantage has been at the forefront of this evolution, seamlessly integrating LIMS with ELN, LES, and SDMS into a unified lab informatics platform. This platform, developed in collaboration with its clients, not only streamlines laboratory processes but also provides critical business intelligence. The robust growth of LabVantage’s professional services organization has enabled the company to support customers anywhere in the world and increase the number of global software deployments by more than 50% year-over-year.

 

The successful implementations of LabVantage LIMS in the past year can be categorized into three distinct business cases as follows:

 
  1. Transition to Automated Data Management: Clients have moved from manual recording processes to the LabVantage LIMS platform for enhanced data management, retrieval, and traceability.
  2. Upgrading to Advanced LIMS: Organizations previously using in-house LIMS systems or other commercial solutions embedded with limited LIMS functionalities have now adopted LabVantage LIMS for more robust capabilities.
  3. Scaling Up Existing LIMS Use: Existing customers of LabVantage LIMS have extended the system to additional laboratories, driven by its proven effectiveness in enhancing laboratory productivity.


“Achieving more than 100 Go-Lives in a single year reflects the strength and scalability of our professional services. Our ability to support clients across diverse industries worldwide demonstrates our expertise in navigating complex laboratory ecosystems,” said Craig Bowie, Vice President of Professional Services at LabVantage Solutions. “The growth we've experienced is not just in numbers; it's in the value we bring to our clients, helping them to manage scientific data more efficiently at every stage. We see our growth as directly aligned with our clients' success – as they upgrade to more sophisticated systems or expand their usage of LabVantage LIMS, they are seeing tangible improvements in their operational productivity. This is the driving force behind our exceptional increase in global software deployments.”

 

For more information on LabVantage and its LIMS solutions, visit www.labvantage.com or email info@labvantage.com.

 

References:

1. Frost RadarTM: Global Laboratory Information Management Systems (LIMS) for the Life Sciences Industry 2023 Report.

About LabVantage Solutions

 

A recognized leader in enterprise laboratory software solutions, LabVantage Solutions dedicates itself to improving customer outcomes by transforming data into knowledge. The LabVantage informatics platform is highly configurable, integrated across a common architecture, and 100% browser-based to support hundreds of concurrent users. Deployed on-premise, via the cloud, or SaaS, it seamlessly interfaces with instruments and other enterprise systems – enabling true digital transformation. The platform consists of the most modern laboratory information management system (LIMS) available, integrated electronic laboratory notebook (ELN), laboratory execution system (LES), scientific data management system (SDMS), and advanced analytics; and, for healthcare settings, a laboratory information system (LIS). We support more than 1500 global customer sites in the life sciences, pharmaceutical, medical device, biobank, food & beverage, consumer packaged goods, oil & gas, genetics/diagnostics, forensic, and healthcare industries. Headquartered in Somerset, NJ, with global offices, LabVantage has offered its comprehensive portfolio of products and services to enable customers to innovate faster in the R&D cycle, improve manufactured product quality, achieve accurate record-keeping, and comply with regulatory requirements for four decades. For more information, visit labvantage.com.

 

 




Latest Images